A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C

NCT00814606 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped no one ever enrolled

Conditions

Hepatitis C
Hepatitis C Virus

Interventions

DRUG: Fluvastatin
DRUG: Peginterferon alfa2a
DRUG: ribavirin

Sponsor

University of Chicago